Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nitu Bansal

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Current Pharmaceutical Biotechnology|February 10, 2009
Tumor initiating cellsNitu Bansal, Debabrata Banerjee
Immunity & Ageing : I & A|April 30, 2026
Inflammaging and the role of micronutrients as immunomodulators: a pathway to healthy agingSheryl S L Tan, Vandana Garg, Abhijeet Dhiman, et al.
Oncotarget|June 4, 2015
Axl receptor tyrosine kinase is up-regulated in metformin resistant prostate cancer cellsNitu Bansal, Prasun J Mishra, Mark Stein, et al.
Molecular Cancer Therapeutics|November 9, 2014
Darinaparsin inhibits prostate tumor-initiating cells and Du145 xenografts and is an inhibitor of hedgehog signalingNitu Bansal, Nadine Johnson Farley, Lisa Wu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 2, 2016
NAD+ Kinase as a Therapeutic Target in CancerPhilip M Tedeschi, Nitu Bansal, John E Kerrigan, et al.
Molecular Pharmacology|July 3, 2009
Species-specific differences in translational regulation of dihydrofolate reductaseYi-Ching Hsieh, Nancy E Skacel, Nitu Bansal, et al.
The Prostate|October 25, 2013
Enrichment of human prostate cancer cells with tumor initiating properties in mouse and zebrafish xenografts by differential adhesionNitu Bansal, Stephani Davis, Irina Tereshchenko, et al.
Oncotarget|October 4, 2018
Modeling and antitumor studies of a modified L-penetratin peptide targeting E2F in lung cancer and prostate cancerTazeem Shaik, Gulam M Rather, Nitu Bansal, et al.
Oncotarget|March 25, 2014
A novel peptide that inhibits E2F transcription and regresses prostate tumor xenograftsXiaoqi Xie, Nitu Bansal, Tazeem Shaik, et al.
Scientific Reports|March 9, 2017
Small molecule inhibitors block Gas6-inducible TAM activation and tumorigenicityStanley G Kimani, Sushil Kumar, Nitu Bansal, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Current Pharmaceutical Biotechnology|February 10, 2009
Tumor initiating cellsNitu Bansal, Debabrata Banerjee
Immunity & Ageing : I & A|April 30, 2026
Inflammaging and the role of micronutrients as immunomodulators: a pathway to healthy agingSheryl S L Tan, Vandana Garg, Abhijeet Dhiman, et al.
Oncotarget|June 4, 2015
Axl receptor tyrosine kinase is up-regulated in metformin resistant prostate cancer cellsNitu Bansal, Prasun J Mishra, Mark Stein, et al.
Molecular Cancer Therapeutics|November 9, 2014
Darinaparsin inhibits prostate tumor-initiating cells and Du145 xenografts and is an inhibitor of hedgehog signalingNitu Bansal, Nadine Johnson Farley, Lisa Wu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 2, 2016
NAD+ Kinase as a Therapeutic Target in CancerPhilip M Tedeschi, Nitu Bansal, John E Kerrigan, et al.
Molecular Pharmacology|July 3, 2009
Species-specific differences in translational regulation of dihydrofolate reductaseYi-Ching Hsieh, Nancy E Skacel, Nitu Bansal, et al.
The Prostate|October 25, 2013
Enrichment of human prostate cancer cells with tumor initiating properties in mouse and zebrafish xenografts by differential adhesionNitu Bansal, Stephani Davis, Irina Tereshchenko, et al.
Oncotarget|October 4, 2018
Modeling and antitumor studies of a modified L-penetratin peptide targeting E2F in lung cancer and prostate cancerTazeem Shaik, Gulam M Rather, Nitu Bansal, et al.
Oncotarget|March 25, 2014
A novel peptide that inhibits E2F transcription and regresses prostate tumor xenograftsXiaoqi Xie, Nitu Bansal, Tazeem Shaik, et al.
Scientific Reports|March 9, 2017
Small molecule inhibitors block Gas6-inducible TAM activation and tumorigenicityStanley G Kimani, Sushil Kumar, Nitu Bansal, et al.
Pageof 2